Schlieren ZH – The health insurance provider Sanitas is supporting a device from the MedTech start-up Pregnolia that is used to detect premature births. It is taking on the costs of the check-up and investing in the company.

Sanitas invests in Pregnolia
© Pregnolia

Pregnolia has developed an instrument to detect the risks of premature birth. To do so, a probe measures the stiffness of the cervix. If it is too soft, the physician can initiate therapeutic measures in good time. One of the start-up’s aims is to identify asymptomatic women who could benefit from intervention in the early stages of pregnancy.

Sanitas is the first health insurance provider in Switzerland to take on the costs of a check-up using the Pregnolia device according to a press release. This is covered within outpatient supplementary insurance. Sanitas is also investing in Pregnolia. According to an article on, there are plans for a “modest” investment. Pregnolia was already able to secure 4 million Swiss francs in a funding round last summer.

Sabrina Badir, CEO and Founder of Pregnolia, is quoted as saying: ““We’re delighted that Sanitas is supporting our startup as we ready the product for broad market release and that, by reimbursing check-ups done using our technology, it is sending out a strong signal for innovation in the market.”

Badir founded Pregnolia as a spin-off from the Swiss Federal Institute of Technology in Zurich (ETH). The start-up is headquartered in Schlieren.

Contact us

Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center? Give us a call or drop us a line. 

+41 44 254 59 59